Ignite Creation Date:
2024-05-06 @ 12:09 AM
Last Modification Date:
2024-10-26 @ 10:45 AM
Study NCT ID:
NCT01506609
Status:
COMPLETED
Last Update Posted:
2021-10-25
First Post:
2012-01-06
Brief Title:
Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide TMZ or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene BRCA1 and BRCA2 Mutation and Metastatic Breast Cancer
Sponsor:
Organization:
AbbVie
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
294
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: